Brief: Ryvu Therapeutics Presents Updated Data On RVU120 At 2022 EHA Congress
10/06/2022 11:31
June 10 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* RYVU THERAPEUTICS PRESENTS UPDATED CLINICAL AND
PRECLINICAL DATA
ON RVU120 AT THE 2022 EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
CONGRESS
Source text for Eikon: ID:nPn4tLPL8a
Further company coverage: RVU.WA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys